Close this search box.
Close this search box.

Syngene’s high potent API manufacturing facility

Our high potent API facility is designed to handle cytotoxic and cytostatic high-potency compounds with a commitment to safety. It has an occupational exposure limit (OEL) of up to 0.01 µg/m over 8 hours and is categorized within Band 4/5. The cGMP facility is positioned to meet the stringent requirements of the regulated market. Additionally, it boasts an integrated cGMP facility dedicated to manufacturing non-potent compounds.


Latest Blogs

pDNA and mRNA manufacturing in the age of Precision Therapies: The role of CDMOs

Leveraging High Throughput Screening services to accelerate drug discovery and development

Harnessing the power of induced proximity-based drugs and precision medicine for treating cancer


Five questions that determine the success of your PROTAC programs


Solving problems with science: Gene to GMP-grade clinical supply in nine months


Minimizing environmental footprint the Syngene way

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details